Jodie Wehling

Vice President of Market Access at Mesoblast

Speaker

Spearheading Market Access, Trade & Distribution, and Pricing &Contracting group at Mesoblast, LLC. My mission is to optimizepatient access to groundbreaking therapies. I developcomprehensive market access strategies, including the pivotal USlaunch of Ryoncil, rexlemestrocel-l and the Allogenic Cell Therapyprogram while ensuring alignment with cross-functional teams todeliver exceptional results. With competencies in trade anddistribution for CAR-T therapies, collaboration to establish a robustpatient services framework, leveraging insights to drive pre-launch,launch, and post-launch strategies is key. My focus lies on creatingsustainable engagement across key customer segments, reflecting